15.09.2014 • News

Bayer Completes Sale of Interventional Device Business

Bayer HealthCare has completed the sale of its interventional device business to Boston Scientific for $ 415 million.

The German company said the divestment will allow its medical care division to concentrate on innovation and growth in radiology and diabetes care, where it already has a strong presence.

The transaction includes the AngioJet (thrombectomy) and Jetstream (atherectomy) systems, and the FetchAspiration catheter used in cardiology, radiology and peripheral vascular procedures.

Bayer's Interventional business had sales of $120 million in 2013.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Top-Feature

most read